The further refinement of ROP treatment. Commentary on the early treatment of retinopathy of prematurity study: Structural findings at 2 years of age

British Journal of Ophthalmology

Volumn 91, Issue 2, 2007, Pages 136-137

  Fielder, Alistair R ^a   Wilkinson, Andrew R ^b  

^a CITY UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLINDNESS; CLINICAL RESEARCH; CLINICAL TRIAL; EDITORIAL; HUMAN; MODEL; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETINA SURGERY; RETINOPATHY; RETROLENTAL FIBROPLASIA; RISK ASSESSMENT; TREATMENT PLANNING;

AGE FACTORS; CHILD, PRESCHOOL; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LASER SURGERY; RANDOMIZED CONTROLLED TRIALS; RETINOPATHY OF PREMATURITY; TREATMENT OUTCOME;

EID: 33846798386     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2006.107813     Document Type: Editorial

References (16)

1. Early Treatment for Retinopathy of Prematurity Cooperative Group. The Early Treatment of Retinopalfiy Of Prematurity Study : structural findings at 2 years of age. Br J Ophthalmol 2006;90:1341-2.
2. Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity. Arch Ophthalmol 2003;121:1684-96.
3. Averbukh E. The evidence supporting the early treatment for type 1 retinopathy of prematurity needs further evaluation. Arch Ophthalmol 2005;123:406.
4. Vander JF, McNamara JA, Tasman W, et al. Revised indications for early treatment of retinopathy of prematurity. Arch Ophthalmol 2005;123:406-7.
5. Jalali S, Essuman VA, Thomas R. Clinical application of the revised indications for the treatment of retinopathy of prematurity. Arch Ophthalmol 2005;123:407-8.
6. Coats D, Sounders R. The dilemma of exercising clinical judgment in the treatment of retinopathy of prematurity. Arch Ophthalmol 2005;123:408-9.
7. Good WV, Hardy RJ. Response to correspondence on revised indication for early treatment of retinopathy of prematurity. Arch Ophthalmol 2005;123:409-10.
8. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results. Arch Ophthalmol 1988;106:471-9.
9. Hardy RJ, Palmer EA, Dobson V, Cryotherapy for Retinopathy of Prematurity Cooperative Group, et al. Risk analysis of prethreshold retinopathy of prematurity. Arch Ophthalmol 2003;121:1697-701.
10. Hardy RJ, Good WV, Dobson V, et al. The early treatment for retinopathy of prematurity clinical trial: presentation by subgroups versus analysis within subgroups. Br J Ophthalmol 2006;90:1341-2.
11. Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Br J Ophthalmol 1984;68:690-7.
12. Capowski JJ, Klystra JA, Freedman SF. A numerical index based on spatial frequency for the tortuosity of retinal vessels and its application to plus disease in retinopathy of prematurity. Retina 1995;15:490- 500.
13. Heneghan C, Flynn J, O'Keefe M, et al. Characterization of changes in blood vessel width and tortuosity in retinopathy of prematurity using image analysis. Med Image Anal 2002;6:407-29.
14. Swanson CR, Cocker KD, Parker KH, et al. Semi-automated computer analysis of retinal vessels in infants with acute-phase retinopathy of prematurity. Br S Ophthalmol 2003;87:1474-7.
15. Wallace DK, Jomier J, Aylward ST, et al. Computer-automated quantification of plus disease in retinopathy of prematurity. JAAPOS 2003;7:126-30.
16. Gelman R, Martinez-Perez ME, Vanderveen DK, et al. Diagnosis of lus disease in retinopathy of prematurity using Retinal Image multiScale Analysis. Invest Ophthalmol Vis Sci 2005;46:4734-8.